OZEM Holdings Information

OZEM is an equity ETF with a total of 25 individual holdings. The top holdings are Novo Nordisk stock at 13.07%, Eli Lilly and Company at 12.57%, Pfizer at 6.54%, CSPC Pharmaceutical Group at 6.39%, and Viking Therapeutics at 5.33%.

Total Holdings

Top 10 Percentage

64.68%

Asset Class

Equity

ETF Category

Health

Assets

62.50M

PE Ratio

13.41

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	NVO	Novo Nordisk A/S	13.07%	168,984
2	LLY	Eli Lilly and Company	12.57%	6,606
3	PFE	Pfizer Inc.	6.54%	165,697
4	HKG: 1093	CSPC Pharmaceutical Group Limited	6.39%	3,728,000
5	VKTX	Viking Therapeutics, Inc.	5.33%	93,822
6	KLRA	Kailera Therapeutics, Inc.	4.92%	176,239
7	4519.JP	Chugai Pharmaceutical Co Ltd	4.27%	60,500
8	ZEAL.DC	Zealand Pharma A/S	4.01%	55,309
9	AMGN	Amgen Inc.	3.96%	6,634
10	KRX: 128940	Hanmi Pharm. Co., Ltd.	3.62%	8,509
11	HKG: 1672	Ascletis Pharma Inc.	3.52%	1,943,000
12	LON: AZN	AstraZeneca PLC	3.41%	12,621
13	MBX	MBX Biosciences, Inc.	3.23%	31,685
14	SWX: ROP	Roche Holding AG	3.14%	4,570
15	GPCR	Structure Therapeutics Inc.	2.90%	35,557
16	HKG: 3933	The United Laboratories International Holdings Limited	2.85%	1,524,000
17	HKG: 3692	Hansoh Pharmaceutical Group Company Limited	2.80%	420,000
18	HKG: 1801	Innovent Biologics, Inc.	2.70%	145,000
19	HKG: 1276	Jiangsu Hengrui Pharmaceuticals Co.,Ltd	2.57%	218,000
20	GUBRA.DC	Gubra A/S	2.05%	23,795
21	GILD	Gilead Sciences, Inc.	1.80%	8,569
22	RYTM	Rhythm Pharmaceuticals, Inc.	1.51%	9,188
23	4507.JP	Shionogi & Co Ltd	1.24%	44,500
24	WVE	Wave Life Sciences Ltd.	0.86%	92,938
25	CHF	SWISS FRANC	n/a	n/a

As of Jul 24, 2026